Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data

Introduction Opioid overdoses have increased substantially over the last 20 years, with over 400 000 deaths in North America. While opioid prescribing has been a target of research, benzodiazepine and opioid co-intoxication has emerged as a potential risk factor. Our aim was to assess the risk of op...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristian B Filion, Robyn Tamblyn, David L Buckeridge, Erin Y Liu
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/2/e042299.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849221275582464000
author Kristian B Filion
Robyn Tamblyn
David L Buckeridge
Erin Y Liu
author_facet Kristian B Filion
Robyn Tamblyn
David L Buckeridge
Erin Y Liu
author_sort Kristian B Filion
collection DOAJ
description Introduction Opioid overdoses have increased substantially over the last 20 years, with over 400 000 deaths in North America. While opioid prescribing has been a target of research, benzodiazepine and opioid co-intoxication has emerged as a potential risk factor. Our aim was to assess the risk of opioid overdose associated with concurrent use of opioids and benzodiazepines relative to opioids alone.Methods and analysis A retrospective cohort study will be conducted using medical claims data from adult residents of Montréal, Canada. We will create a cohort of new users of opioids (ie, no opioid dispensations in prior year) in 2000–2014 from people with at least 2 years of continuous health insurance. Those with any diagnosis or hospitalisation for cancer or palliative care in the 2 years before their first opioid dispensation will be excluded. On each person-day of follow-up, exposure status will be classified into one of four mutually exclusive categories: (1) opioid-only, (2) benzodiazepine-only, (3) both opioid and benzodiazepine (concurrent use) or (4) neither. Opioid overdose will be measured using diagnostic codes documented in the hospital discharge abstract database, physician billing claims from emergency department visits and death records. Using a marginal structural Cox proportional hazards model, we will compare the hazard of overdose during intervals of concurrent opioid and benzodiazepine use to intervals of opioid use alone, adjusted for sociodemographics, medical and psychiatric comorbidities, and substance use disorders.Ethics and dissemination This study is approved by the McGill Faculty of Medicine Institutional Review Board and the Commission d’access à l’information (Québec privacy commission). Results will be relevant to clinicians, policymakers and other researchers interested in co-prescribing practices of opioids and benzodiazepines. Study findings will be disseminated at relevant conferences and published in biomedical and epidemiological peer-reviewed journals.
format Article
id doaj-art-2ecce0bf0dce40c08f901084de5bf18a
institution Kabale University
issn 2044-6055
language English
publishDate 2021-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-2ecce0bf0dce40c08f901084de5bf18a2024-11-17T08:00:08ZengBMJ Publishing GroupBMJ Open2044-60552021-02-0111210.1136/bmjopen-2020-042299Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative dataKristian B Filion0Robyn Tamblyn1David L Buckeridge2Erin Y Liu3Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, CanadaMcGill Clinical and Health Informatics, McGill University, Montréal, Quebec, CanadaDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montréal, Québec, CanadaDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, CanadaIntroduction Opioid overdoses have increased substantially over the last 20 years, with over 400 000 deaths in North America. While opioid prescribing has been a target of research, benzodiazepine and opioid co-intoxication has emerged as a potential risk factor. Our aim was to assess the risk of opioid overdose associated with concurrent use of opioids and benzodiazepines relative to opioids alone.Methods and analysis A retrospective cohort study will be conducted using medical claims data from adult residents of Montréal, Canada. We will create a cohort of new users of opioids (ie, no opioid dispensations in prior year) in 2000–2014 from people with at least 2 years of continuous health insurance. Those with any diagnosis or hospitalisation for cancer or palliative care in the 2 years before their first opioid dispensation will be excluded. On each person-day of follow-up, exposure status will be classified into one of four mutually exclusive categories: (1) opioid-only, (2) benzodiazepine-only, (3) both opioid and benzodiazepine (concurrent use) or (4) neither. Opioid overdose will be measured using diagnostic codes documented in the hospital discharge abstract database, physician billing claims from emergency department visits and death records. Using a marginal structural Cox proportional hazards model, we will compare the hazard of overdose during intervals of concurrent opioid and benzodiazepine use to intervals of opioid use alone, adjusted for sociodemographics, medical and psychiatric comorbidities, and substance use disorders.Ethics and dissemination This study is approved by the McGill Faculty of Medicine Institutional Review Board and the Commission d’access à l’information (Québec privacy commission). Results will be relevant to clinicians, policymakers and other researchers interested in co-prescribing practices of opioids and benzodiazepines. Study findings will be disseminated at relevant conferences and published in biomedical and epidemiological peer-reviewed journals.https://bmjopen.bmj.com/content/11/2/e042299.full
spellingShingle Kristian B Filion
Robyn Tamblyn
David L Buckeridge
Erin Y Liu
Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
BMJ Open
title Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
title_full Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
title_fullStr Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
title_full_unstemmed Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
title_short Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data
title_sort concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose protocol for a retrospective cohort study using linked administrative data
url https://bmjopen.bmj.com/content/11/2/e042299.full
work_keys_str_mv AT kristianbfilion concurrentprescriptionsforopioidsandbenzodiazepinesandriskofopioidoverdoseprotocolforaretrospectivecohortstudyusinglinkedadministrativedata
AT robyntamblyn concurrentprescriptionsforopioidsandbenzodiazepinesandriskofopioidoverdoseprotocolforaretrospectivecohortstudyusinglinkedadministrativedata
AT davidlbuckeridge concurrentprescriptionsforopioidsandbenzodiazepinesandriskofopioidoverdoseprotocolforaretrospectivecohortstudyusinglinkedadministrativedata
AT erinyliu concurrentprescriptionsforopioidsandbenzodiazepinesandriskofopioidoverdoseprotocolforaretrospectivecohortstudyusinglinkedadministrativedata